Literature DB >> 8789447

Bi-directional dideoxy fingerprinting (Bi-ddF): a rapid method for quantitative detection of mutations in genomic regions of 300-600 bp.

Q Liu1, J Feng, S S Sommer.   

Abstract

There is a great need for rapid screening methods that detect essentially all mutations. Dideoxy fingerprinting (ddF) is a highly sensitive screening method that is performed by electrophoresing one lane of a Sanger dideoxy termination reaction through a nondenaturing gel. Mutations may produce an extra segment or eliminate a segment from the termination products (informative dideoxy component). In addition, mutations can be detected by the altered mobility of one or more termination segments (informative SSCP component). To screen larger segments with virtually 100% sensitivity, bi-directional ddF (Bi-ddF) was developed. Bi-ddF is a 'second generation ddF' in which the dideoxy termination reaction is performed simultaneously with two opposing primers. Bi-ddF has two important advantages over ddF: (i) the dideoxy component can detect 10 of the 12 types of possible single-base substitutions; and (ii) the SSCP component is enhanced because alterations of mobility can be detected in either the downstream or upstream direction. As a result, Bi-ddF can screen larger regions of genomic DNA with virtually 100% sensitivity. Bi-ddF detected 100% of 28 single-base substitutions in a 494 bp segment containing exons B and C of the human factor IX gene and 100% of 42 single-base substitutions and one microdeletion present in a 577 bp region containing exon H. In a blinded analysis in which 39 wildtype samples were randomly mixed with 51 mutant samples, all mutations were detected with no false positives. Bi-ddF requires essentially the same effort as ddF, yet twofold more DNA sequence can be screened reliably per unit effort.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8789447     DOI: 10.1093/hmg/5.1.107

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  8 in total

Review 1.  Automated mutation analysis.

Authors:  D Ravine
Journal:  J Inherit Metab Dis       Date:  1999-06       Impact factor: 4.982

Review 2.  PCR-SSCP: a method for the molecular analysis of genetic diseases.

Authors:  V Konstantinos Kakavas; Kakavas V Konstantinos; Panagiotis Plageras; Plageras Panagiotis; T Antonios Vlachos; Vlachos T Antonios; Agelos Papaioannou; Papaioannou Agelos; V Argiris Noulas; Noulas V Argiris
Journal:  Mol Biotechnol       Date:  2007-10-13       Impact factor: 2.695

3.  Identification of a new splice form of the EDA1 gene permits detection of nearly all X-linked hypohidrotic ectodermal dysplasia mutations.

Authors:  A W Monreal; J Zonana; B Ferguson
Journal:  Am J Hum Genet       Date:  1998-08       Impact factor: 11.025

4.  Factor H mutations in hemolytic uremic syndrome cluster in exons 18-20, a domain important for host cell recognition.

Authors:  A Richards; M R Buddles; R L Donne; B S Kaplan; E Kirk; M C Venning; C L Tielemans; J A Goodship; T H Goodship
Journal:  Am J Hum Genet       Date:  2001-01-17       Impact factor: 11.025

5.  Novel compound heterozygous mutations in the KCNQ1 gene associated with autosomal recessive long QT syndrome (Jervell and Lange-Nielsen syndrome).

Authors:  Li Ning; Arthur J Moss; Wojciech Zareba; Jennifer Robinson; Spencer Rosero; Dan Ryan; Ming Qi
Journal:  Ann Noninvasive Electrocardiol       Date:  2003-07       Impact factor: 1.468

6.  Toward a fluorescent single-strand conformation polymorphism technique that detects all mutations: F-DOVAM-S.

Authors:  Cameron Mroske; John Muci; Jicheng Wang; Kai Li; Wenjia Song; Jin Yan; Jinong Feng; Qiang Liu; Steve S Sommer
Journal:  Anal Biochem       Date:  2007-05-26       Impact factor: 3.365

7.  Towards Automation for Molecular Diagnosis of Cancer.

Authors:  Maurizio Ferrari; Paola Carrera
Journal:  EJIFCC       Date:  2005-05-17

Review 8.  Molecular approaches in the diagnosis of primary immunodeficiency diseases.

Authors:  Maurizio Costabile; Alex Quach; Antonio Ferrante
Journal:  Hum Mutat       Date:  2006-12       Impact factor: 4.878

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.